New Ray Medicine International Holding Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 33
Employees
  • Stock Symbol
  • 06108
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.05
  • (As of Wednesday Closing)

New Ray Medicine International Holding General Information

Description

New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • Room 517, 5th Floor, Town Health Technology Centre
  • 10-12 Yuen Shun Circuit, Siu Lek Yuen, Shatin, New Territories
  • Hong Kong
  • Hong Kong
+852 2210 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

New Ray Medicine International Holding Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.06 $0.03 - $0.11 $91M 1.67B 10.2M -$0.01

New Ray Medicine International Holding Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 80,570 79,831 77,639 75,110
Revenue 17,010 15,140 47,518 30,188
EBITDA (8,978) (5,148) 5,420 (11,626)
Net Income (9,332) (5,629) 4,236 (13,475)
Total Assets 79,204 87,167 98,061 106,281
Total Debt 315 280 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

New Ray Medicine International Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore New Ray Medicine International Holding‘s full profile, request access.

Request a free trial

New Ray Medicine International Holding Executive Team (4)

Name Title Board Seat Contact Info
Linxing He Director of Subsidiaries of the Company
Lee Yuet Executive Director
Yang Fang Executive Director
You’re viewing 3 of 4 executive team members. Get the full list »

New Ray Medicine International Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

New Ray Medicine International Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore New Ray Medicine International Holding‘s full profile, request access.

Request a free trial

New Ray Medicine International Holding Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 000000 10-Apr-2017 000000000 00000000 000.00 Asset Management
To view New Ray Medicine International Holding’s complete investments history, request access »